Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,900 | -13,988 | -8,664 | -4,146 | 2,509 |
| Depreciation Amortization | 2,805 | 680 | 690 | 758 | -4,465 |
| Income taxes - deferred | -6,482 | -4,568 | -1,480 | -246 | -1,286 |
| Accounts receivable | -13,012 | -8,581 | -7,751 | -2,587 | -707 |
| Accounts payable and accrued liabilities | 1,708 | 3,835 | 4,304 | 1,165 | -10,984 |
| Other Working Capital | -6,558 | -7,276 | 2,365 | 6,978 | -747 |
| Other Operating Activity | 24,682 | 15,958 | 11,177 | 5,647 | 28,481 |
| Operating Cash Flow | $-15,757 | $-13,940 | $641 | $7,569 | $12,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,719 | -4,505 | -4,344 | -2,712 | -101,048 |
| Purchase Of Investment | -364,773 | -272,369 | -188,636 | -76,006 | -512,606 |
| Sale Of Investment | 352,062 | 255,451 | 159,500 | 60,500 | 601,598 |
| Investing Cash Flow | $-17,430 | $-21,423 | $-33,480 | $-18,218 | $-12,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -155 | 0 | N/A | N/A | N/A |
| Financing Cash Flow | $-155 | $0 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -163 | 39 | -29 | -14 | 47 |
| Beginning Cash Position | 136,290 | 136,290 | 136,290 | 136,290 | 135,498 |
| End Cash Position | 102,785 | 100,966 | 103,422 | 125,627 | 136,290 |
| Net Cash Flow | $-33,505 | $-35,324 | $-32,868 | $-10,663 | $792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,757 | -13,940 | 641 | 7,569 | 12,801 |
| Capital Expenditure | -4,719 | -4,505 | -4,344 | -2,712 | -101,048 |
| Free Cash Flow | -20,476 | -18,445 | -3,703 | 4,857 | -88,247 |